Endocrine Society: Telehealth Is Well-Suited for Hormonal Care, With Caveats
A policy perspective from the Endocrine Society finds that endocrinology is well-suited to telehealth because most hormonal management relies on labs and patient history rather than physical examination, though clinician adoption concerns persist.
Read the original article at The Journal of Clinical Endocrinology & MetabolismKairos™'s Take
Kairos™'s perspective on this story
The COVID-19 pandemic forced a rapid telehealth expansion across medicine, and endocrinology turned out to be one of the specialties best suited for it. A policy perspective published in the Journal of Clinical Endocrinology & Metabolism by a nine-member panel of US endocrinologists explains why: the diagnosis and management of most endocrine conditions rely primarily on patient-reported history, laboratory results, and imaging rather than physical examination. Thyroid management, diabetes care, testosterone monitoring, and menopause treatment can all be conducted effectively through video visits when paired with local lab draws.
The benefits for patients are substantial, particularly for those in rural areas or those managing chronic hormonal conditions that require regular but routine follow-up. Eliminating travel time, reducing missed work, and increasing appointment availability all improve adherence to treatment plans. For hormonal care specifically, where treatment adjustments are often based on lab trends rather than physical findings, telehealth can deliver equivalent quality to in-person visits for established patients.
The panel also identified limitations. Initial evaluations for thyroid nodules, adrenal masses, or suspected gonadal abnormalities may require hands-on examination. Clinician concerns about rapport-building and clinical appropriateness remain, and some providers prefer in-person visits for patient populations they perceive as less comfortable with technology. These concerns are valid but solvable with better telehealth platforms and patient preparation.
The policy direction is clear: telehealth in endocrinology is not a temporary pandemic accommodation. It is a permanent expansion of access that requires thoughtful implementation rather than wholesale adoption or rejection.
The Tracking Connection
Kairos™ makes telehealth visits more productive by ensuring that patients arrive with organized, longitudinal data rather than scattered recollections. When a provider can review six months of tracked labs, symptoms, and lifestyle data before a video visit, the 15-minute appointment becomes dramatically more efficient. Kairos is the preparation layer that turns telehealth from a convenience into a clinical upgrade.
Ready to start tracking?
Kairos™ tracks, scores, and interprets the symptoms of midlife hormonal change — for both women and men.
Get StartedMore from the newsroom
Longitudinal Health Monitoring Can Predict Disease 5-7 Years Before Diagnosis
Research on digital biomarker monitoring shows that longitudinal tracking of health data can identify high-risk individuals years before clinical diagnosis, enabling targeted prevention for type 2 diabetes, cardiovascular disease, and other chronic conditions.
Untreated Menopause Costs the US $26.6 Billion Per Year, Mayo Clinic Finds
A Mayo Clinic study finds menopause symptoms cost $1.8 billion annually in lost work time and $26.6 billion when medical expenses are added, with 13% of working women reporting at least one adverse work outcome due to symptoms.
44% of Americans Now Own Health Wearables, Up From 33% in 2019
Rock Health's annual Digital Health Consumer Adoption Survey finds wearable health device ownership has jumped 10 points since 2019, with 86% of patients reporting improved health outcomes from wearable technology.